HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Qi Deng Selected Research

Infections

5/2024A mathematical model for HIV dynamics with multiple infections: implications for immune escape.
2/2021Humanized anti-CD19 chimeric antigen receptor-T cell therapy is safe and effective in lymphoma and leukemia patients with chronic and resolved hepatitis B virus infection.
8/2015A Prospective Observational Study of Antibiotic Therapy in Febrile Neutropenia Patients with Hematological Malignances from Multiple centers in Northeast China.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Qi Deng Research Topics

Disease

15Neoplasms (Cancer)
08/2023 - 10/2014
9Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
12/2023 - 01/2020
8Cytokine Release Syndrome
01/2024 - 01/2019
8Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2024 - 01/2021
8Leukemia
12/2023 - 06/2009
7Inflammation (Inflammations)
01/2024 - 01/2017
6Lymphoma (Lymphomas)
02/2024 - 06/2019
5B-Cell Lymphoma (Lymphoma, B Cell)
02/2024 - 10/2014
4Disease Progression
12/2023 - 02/2018
3Infections
05/2024 - 08/2015
3Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
07/2023 - 11/2019
3B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
01/2022 - 11/2020
3Mycoses (Diseases, Fungus)
10/2021 - 01/2018
2Brain Diseases (Brain Disorder)
12/2023 - 11/2021
2Multiple Myeloma
04/2022 - 01/2021
2Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
03/2022 - 07/2021
2Residual Neoplasm
01/2022 - 11/2020
2Hematologic Neoplasms (Hematological Malignancy)
07/2021 - 01/2018
2Lymphatic Metastasis
03/2021 - 01/2020
2Hepatocellular Carcinoma (Hepatoma)
03/2021 - 01/2020
2Osteosarcoma (Osteogenic Sarcoma)
03/2020 - 01/2019
2Chondroma (Enchondroma)
01/2019 - 01/2019
2Tuberculosis (Tuberculoses)
02/2018 - 03/2016
2Agranulocytosis (Granulocytopenia)
09/2013 - 12/2012
1Hyperuricemia
04/2024
1Cytopenia
01/2024
1Pneumonia (Pneumonitis)
12/2023
1Coinfection
12/2023
1Pathologic Constriction (Stenosis)
12/2023
1Necrosis
09/2023
1Mesothelioma
08/2023
1Poisoning
05/2023
1Shock
01/2023
1HIV Infections (HIV Infection)
01/2023
1Hyperglycemia
12/2022
1Nervous System Diseases (Neurological Disorders)
12/2022
1Liver Diseases (Liver Disease)
11/2022
1Ataxia (Dyssynergia)
01/2022
1Lymphoproliferative Disorders (Lymphoproliferative Disorder)
01/2022
1Breast Neoplasms (Breast Cancer)
11/2021

Drug/Important Bio-Agent (IBA)

22Chimeric Antigen ReceptorsIBA
02/2024 - 01/2019
6Proteins (Proteins, Gene)FDA Link
11/2022 - 08/2014
4ibrutinibIBA
03/2022 - 11/2020
3Interleukin-6 (Interleukin 6)IBA
01/2024 - 02/2022
3CytokinesIBA
12/2023 - 06/2009
2Polysaccharides (Glycans)IBA
01/2024 - 08/2014
2Agammaglobulinaemia Tyrosine KinaseIBA
07/2023 - 01/2022
2Immune Checkpoint InhibitorsIBA
04/2023 - 01/2020
2Antigen Receptors (Antigen Receptor)IBA
04/2023 - 01/2022
2Volatile Fatty AcidsIBA
02/2023 - 02/2022
2bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA
04/2022 - 01/2021
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
02/2022 - 06/2009
2Annexin A7 (Synexin)IBA
03/2021 - 01/2020
2JNK Mitogen-Activated Protein KinasesIBA
03/2021 - 01/2020
2LigandsIBA
01/2020 - 02/2016
2Messenger RNA (mRNA)IBA
06/2019 - 10/2014
2EnzymesIBA
01/2018 - 03/2016
1Urea (Carbamide)FDA LinkGeneric
04/2024
1Uric Acid (Urate)IBA
04/2024
1NitrogenIBA
04/2024
1Butyric Acid (Butanoic Acid)IBA
01/2024
1Glutamic Acid (Glutamate)FDA Link
01/2024
1Serotonin (5 Hydroxytryptamine)IBA
01/2024
1blinatumomabIBA
12/2023
16-chloropenicillanic acid S-sulfoxideIBA
12/2023
1Fluconazole (Zonal)FDA LinkGeneric
09/2023
1zimberelimabIBA
08/2023
1Cisplatin (Platino)FDA LinkGeneric
08/2023
1Pemetrexed (MTA)FDA Link
08/2023
1Docosahexaenoic AcidsIBA
05/2023
1Capsaicin (Zostrix)FDA Link
02/2023
1Broadly Neutralizing AntibodiesIBA
01/2023
1SpermidineIBA
12/2022
1Glucose (Dextrose)FDA LinkGeneric
12/2022
1Protein HydrolysatesFDA Link
11/2022
1Bispecific AntibodiesIBA
10/2022
1B7-H1 AntigenIBA
10/2022
1AntioxidantsIBA
08/2022
1MycotoxinsIBA
08/2022
1Interleukin-10 (Interleukin 10)IBA
02/2022
1Immunoglobulin M (IgM)IBA
02/2022
1Immunoglobulin G (IgG)IBA
02/2022
1HLA Antigens (Human Leukocyte Antigens)IBA
01/2022
1venetoclaxIBA
01/2022
1Etoposide (VP 16)FDA LinkGeneric
01/2022
1daratumumabIBA
01/2022
1indium arsenide (InAs)IBA
01/2022
1DNA (Deoxyribonucleic Acid)IBA
01/2022
1zanubrutinibIBA
01/2022
1Antineoplastic Agents (Antineoplastics)IBA
11/2021

Therapy/Procedure

25Therapeutics
01/2024 - 01/2011
9Drug Therapy (Chemotherapy)
08/2023 - 01/2011
5Salvage Therapy
12/2023 - 01/2021
3Hematopoietic Stem Cell Transplantation
07/2023 - 01/2020
3Immunotherapy
10/2022 - 06/2009
2Radiotherapy
01/2021 - 01/2020
1Highly Active Antiretroviral Therapy (HAART)
05/2024
1Withholding Treatment
01/2023
1Cell- and Tissue-Based Therapy (Cell Therapy)
03/2022
1Stem Cell Transplantation
01/2022